Oliveira, Susyane Vieira and Amorim, Ana Cristina Ferreira Garcia and Lima, Talita Oliveira and Silva, Gabriela Laís da and Oliveira, Juliana Regina de and Rodrigues, Maria Fernanda Setúbal Destro and Cecatto, Rebeca Boltes (2024) Exploring Photobiomodulation Therapy for Long COVID Xerostomia: A Randomized Controlled Pilot Trial. Journal of Advances in Medicine and Medical Research, 36 (11). pp. 353-366. ISSN 2456-8899
Cecatto36112024JAMMR126540.pdf - Published Version
Download (418kB)
Abstract
Aims: To investigate the effects of a photobiomodulation protocol in the treatment of long COVID-19 xerostomia
Study Design: This is a single-center, randomized, controlled, double-blind pilot clinical trial.
Methodology: 10 patients with long COVID-19 xerostomia are randomized into two groups. The participants receive a standard xerostomia treatment and also a low-intensity photobiomodulation therapy or placebo photobiomodulation therapy on the cutaneous topography of the salivary glands (a RED LED cluster, 2 J/cm2, 108 J per session, twice a week for six weeks). The outcomes measured using the Oral Health Impact Profile (OHIP-14), Xerostomia Inventory (XI) Scale, Brazilian version of SF-36 Quality of Life Scale, Brazilian Version of Functional Independence Measure (FIM), sialometry and salivary pH before and after the therapeutic period of six weeks of intervention.
Results: there were no significant differences between the photobiomodulation and placebo groups in the baseline or post-intervention moments for evaluated outcomes. In the individual analysis of the OHIP-14 and XI items, a difference was observed in the values of the PBM group comparing the pre-intervention baseline moment with the post-intervention PBM moment, not founded in the placebo group. No adverse effects are reported.
Conclusion: This PBM protocol was not superior to placebo in treating long COVID xerostomia for the evaluated outcomes. This study has limitations such as the small sample size and unblinding issues, which may have leading to a lack of significant results for primary outcomes in both the PBM and placebo groups. PBM irradiation of the salivary glands could be studied as a future approach to improving salivary production in patients with xerostomia due to long COVID.
Item Type: | Article |
---|---|
Subjects: | Archive Paper Guardians > Medical Science |
Depositing User: | Unnamed user with email support@archive.paperguardians.com |
Date Deposited: | 26 Nov 2024 07:05 |
Last Modified: | 03 Dec 2024 05:09 |
URI: | http://archives.articleproms.com/id/eprint/2984 |